Status:
ACTIVE_NOT_RECRUITING
Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma
Lead Sponsor:
Duke University
Collaborating Sponsors:
Duke Clinical Research Institute
Bristol-Myers Squibb
Conditions:
Metastatic Renal Cell Carcinoma
Eligibility:
All Genders
19+ years
Brief Summary
ODYSSEY RCC is a prospective, observational Phase IV study is to understand the cancer management and health-related quality of life in patients with mRCC in routine real-world clinical practice in th...
Detailed Description
This trial is a prospective, observational Phase IV study is to understand the cancer management and health-related quality of life in patients with mRCC in routine real-world clinical practice in the...
Eligibility Criteria
Inclusion
- Age 19 or over at time of informed consent.
- Diagnosis of metastatic renal cell cancer (mRCC) with less than or equal to (≤) 3 months of first-line systemic therapy or less than or equal to (≤) 3 months of second-line systemic therapy for mRCC.
- Prior surgery and radiation therapy are permitted.
- Prior neoadjuvant and adjuvant therapy for non-metastatic renal cell carcinoma are permitted.
- Patients currently not on therapy and being observed are permitted.
- Evidence of signed and dated informed consent document indicating that the patient has been informed of all pertinent aspects of the study.
- Ability to comply with completion of PROs
Exclusion
- Patients being treated for metastatic solid tumors other than mRCC are excluded. Non-cytotoxic oral agents for adjuvant or maintenance therapy of other cancers are permitted.
- Patients who are not intending to undergo follow up care at a study site within PCORnet
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2026
Estimated Enrollment :
468 Patients enrolled
Trial Details
Trial ID
NCT04919122
Start Date
April 1 2022
End Date
July 1 2026
Last Update
August 19 2025
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
State University of Iowa
Iowa City, Iowa, United States, 52242
2
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
3
Ochsner Clinic Foundation d/b/a Ochsner Health
New Orleans, Louisiana, United States, 70121
4
The Johns Hopkins University
Baltimore, Maryland, United States, 21205